Skip to Content

Belzutifan (Welireg)

Treatment Taken by Mouth

Generic : Belzutifan (bel-ZOO-tih-fan)
Brand : Welireg (WEL-ih-reg)
Download In :

English

 | 
Last Update : July 05, 2026

About this Treatment

Belzutifan is used for people with von Hippel-Lindau (VHL) disease who need treatment for a type of kidney cancer called renal cell carcinoma (RCC), tumors in the brain and spinal cord called central nervous system hemangioblastomas (CNS), or a type of pancreatic cancer called pancreatic neuroendocrine tumors (pNET). It is also used for a type of kidney cancer called RCC and neuroendocrine tumors called pheochromocytoma or paraganglioma (PPGL).

What are Patient Education Sheets (PES)?

A Patient Education Sheet (PES) is a practical tool created with the unique needs of patients with cancer in mind. Each sheet translates complex treatment information into clear, patient-friendly language. They provide easy-to-follow medication schedules and guidance on managing potential side effects, helping patients and their caregivers feel informed and supported.

These resources are pulled directly by healthcare providers, who can download and print them for distribution during patient visits. This ensures that patients and caregivers leave the clinic with a reliable, easy-to-understand reference tailored to their treatment.

In addition to the standard content, PES documents are also editable in designated sections. Providers can add personalized details such as counseling notes, local resources, or contact information, making each sheet specific to the patient’s care journey.